Mon, April 18, 2022
Sun, April 17, 2022
Thu, April 14, 2022
Wed, April 13, 2022
Tue, April 12, 2022
Mon, April 11, 2022
Sun, April 10, 2022
Fri, April 8, 2022

Andrew Berens Maintained (ZNTL) at Buy with Decreased Target to $67 on, Apr 12th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-67-on-apr-12th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Berens of SVB Leerink, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Decreased Target from $78 to $67 on, Apr 12th, 2022.

Andrew has made no other calls on ZNTL in the last 4 months.



There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $74 on, Monday, April 11th, 2022
  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $67 on, Wednesday, April 6th, 2022

Publication Contributing Sources